Literature DB >> 25843893

Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.

S E Cremer1, S G Moesgaard2, C E Rasmussen2, N E Zois3, T Falk4, M J Reimann1, S Cirera5, H Aupperle6, M A Oyama7, L H Olsen8.   

Abstract

Canine Myxomatous mitral valve disease (MMVD) is an age-related disease. Serotonin (5-HT) is implicated in the pathogenesis as locally-produced or platelet-derived. Involvement of the 5-HT2A receptor (R) and 5-HT2BR in the induction of myxomatous-mediating valvular myofibroblasts (MF) has been suggested. In an age-matched population of dogs with non-clinical and clinical MMVD, the objectives were to investigate (1) gene expression of 5-HT2AR and 5-HT2BR, (2) protein expression and spatial relationship of 5-HT2AR, 5-HT2BR and MF in the mitral valve (MV) and the cardiac anterior papillary muscle (AP) and (3) serum 5-HT concentrations. Gene expression of 5-HT2BR was significantly higher in MV and AP among dogs with clinical MMVD. This was not found for 5-HT2BR protein expression, though association of 5-HT2BR with myxomatous pathology and co-localization of 5-HT2BR and MF in MV and AP support a functional relationship, perhaps perpetuation of clinical MMVD. 5-HT2AR-expression and serum 5-HT showed no differences between groups.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-HT(2A)R; 5-HT(2B)R; CKCS; Dog; Heart valve disease; MMVD

Mesh:

Substances:

Year:  2015        PMID: 25843893     DOI: 10.1016/j.rvsc.2015.03.020

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  9 in total

1.  The role of 5-HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.

Authors:  Estelle Ayme-Dietrich; Roland Lawson; Francine Côté; Claudia de Tapia; Sylvia Da Silva; Claudine Ebel; Béatrice Hechler; Christian Gachet; Jérome Guyonnet; Hélène Rouillard; Jordane Stoltz; Emily Quentin; Sophie Banas; François Daubeuf; Nelly Frossard; Bernard Gasser; Jean-Philippe Mazzucotelli; Olivier Hermine; Luc Maroteaux; Laurent Monassier
Journal:  Br J Pharmacol       Date:  2017-10-15       Impact factor: 8.739

Review 2.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

3.  Serotonin and catecholamines in the development and progression of heart valve diseases.

Authors:  Elliott Goldberg; Juan B Grau; Jacqueline H Fortier; Elisa Salvati; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

4.  Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease.

Authors:  Chang-Min Lee; Jae-Ik Han; Min-Hee Kang; Seung-Gon Kim; Hee-Myung Park
Journal:  J Vet Sci       Date:  2018-01-31       Impact factor: 1.672

Review 5.  Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis.

Authors:  Leah A Pagnozzi; Jonathan T Butcher
Journal:  Front Cardiovasc Med       Date:  2017-12-22

6.  ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.

Authors:  Bruce W Keene; Clarke E Atkins; John D Bonagura; Philip R Fox; Jens Häggström; Virginia Luis Fuentes; Mark A Oyama; John E Rush; Rebecca Stepien; Masami Uechi
Journal:  J Vet Intern Med       Date:  2019-04-11       Impact factor: 3.333

7.  Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.

Authors:  J Ethan Joll; Cynthia R Clark; Christine S Peters; Michael A Raddatz; Matthew R Bersi; W David Merryman
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

8.  Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.

Authors:  Maria J Reimann; Merete Fredholm; Signe E Cremer; Liselotte B Christiansen; Kathryn M Meurs; Jacob E Møller; Jens Häggström; Jens Lykkesfeldt; Lisbeth H Olsen
Journal:  J Vet Intern Med       Date:  2021-10-02       Impact factor: 3.333

Review 9.  Metabolic Reprogramming, Gut Dysbiosis, and Nutrition Intervention in Canine Heart Disease.

Authors:  Qinghong Li
Journal:  Front Vet Sci       Date:  2022-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.